INTERNATIONAL JOURNAL REHABILITATION AND PALLIATIVE MEDICINE.2015.1(1):93-95 
 

Новые подходы к адекватному обезболиванию у онкологических пациентов 
 

Рыспаева Д. Э., Дудниченко А. С.

Харьковская медицинская академия последипломного образования, кафедра онкологии и детской онкологии 
 

Ключевые слова: опухоль-ассоциированная нейропатическая боль, лестница обезболивания, габапентин, прегабалин (Лирика). 
 

ЛИТЕРАТУРА

1. Лечение хронической боли онкологического генеза. Учебн пособ. Под ред. проф. ГА Новикова, проф. НА Осиповой. М, Общероссийское общественное движение «Медицина за качество жизни. 2005: 84.

2. Mishra S, Bhatnagar S, Goyal GN et al. 2012. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care. 29(3): 177–82. http://dx.doi.org/10.1177/1049909111412539; PMid:21745832

3. Dapas F, Hartman SF, Martinez L et al. 1985. Baclofen for the treatment of acute low-back syndrome. A double-blind comparison with placebo. Spine. 10(4): 345–9. http://dx.doi.org/10.1097/00007632-198505000-00010; PMid:2931831

4. Brant JM. 2014. Pain. Cancer Symptom Management. Еd 4. Burlington MA.

5. Cielito C et al. 2009. Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel. J Pain. 10(11): 1146–1150. http://dx.doi.org/10.1016/j.jpain.2009.04.006; PMid:19595634 PMCid:PMC2783933

6. Ross JR, Goller K, Hardy J et al. 2005. Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study. J Palliat Med. 8(6): 1118–26. http://dx.doi.org/10.1089/jpm.2005.8.1118; PMid:16351524

7. Levien TL. 2004. Summary of new drug applications and biologic license applications submitted to the Food and Drug Administration: Pregabalin-Pfizer. Advances in Pharmacy. 2(2): 185–186.

8. Toelle TR et al. 2012. Pregabalin in Neuropathic Pain Related to DPN, Cancer and Back Pain: Analysis of a 6-Week Observational Study. The Open Pain Journal. 5: 1–11.

9. Lesser H, Sharma U, LaMoreaux L et al. 2004. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology. 63(11): 2104–10. http://dx.doi.org/10.1212/01.WNL.0000145767.36287.A1; PMid:15596757

10. Toru et al. 2014. Principles and Management of Cancer Pain. Merit Research Journals. 2(6): 124–129.

11. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain (APS). Sixth Edition. 2008: 120.

12. Golubovič V et al. 2011. Recent advantages in cancer pain management. Periodicum Biologorum. 113;2: 261–264.

13. Rice AS, Maton S. 2001. Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain. 94: 215–224.

14. Ripamonti CI, Santini D, Maranzo E. 2012. Management of Cancer pain: ESMO Clinical Practice Guidelines. Annals of Oncology. 23; Suppl 7: 139–154.

15. Serpell MG. 2002. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain. 99: 557–566.

16. Harke H, Gretenkort P, Ladleif HU et al. 2001. The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study. Anesth Analg. 92(2): 488–95. http://dx.doi.org/10.1097/00000539-200102000-00039; http://dx.doi.org/10.1213/00000539-200102000-00039; PMid:11159256